Bagno LL, Kanashiro-Takeuchi RM, Suncion VY, et al
Research demonstrates that these medications can support significant weight loss when combined with lifestyle modifications
Lastly, our study cohort was predominantly Caucasian and male, reflective of the population cared for within the VHA system, thus results may not be generalizable to a wider population, although some recent studies found that VHA population have similar health characteristics as individuals with other insurance coverage suggesting greater generalizability
These include improving vascular function, reducing systemic inflammation, enhancing coronary microvascular function, and mitigating comorbid conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD)
(2025) "Product Information